甲状腺滤泡癌的综合遗传分析可独立于组织学预测预后
结果显示总突变负荷在各亚型间一致,中位数为10个(范围1-44)非同义体细胞突变;20.5%标本有RAS亚家族突变,亚型间无显著差异。eaFTC和wiFTC队列疾病特异性生存较差,miFTC患者无复发或死亡;突变负荷与更差预后相关,独立于组织病理学分类。
要点
- FTC各组织学亚型间总突变负荷一致,中位10个非同义体细胞突变。
- 20.5%的FTC标本存在RAS亚家族突变,亚型间无显著差异。
- 突变负荷是死亡和复发的独立预测因素,独立于组织学分类。
核心结论
- 尽管不同组织病理学亚型的FTC体细胞变异数目和种类相似,但突变负荷是死亡和复发的独立预测因素。
主要发现
- 总突变负荷在各FTC亚型间一致,中位数为10个(范围1-44)非同义体细胞突变。
- 20.5%的标本有RAS亚家族(HRAS、KRAS或NRAS)突变,亚型间无显著差异。
- TSHR、DICER1、EIF1AX、KDM5C、NF1、PTEN和TP53突变在队列中反复出现。
- 克隆性分析显示wiFTC有更多亚克隆。
- 生存分析显示eaFTC和wiFTC队列疾病特异性生存较差,miFTC患者无复发或死亡。
关键数值与推荐
- 总突变负荷中位数为10个(范围1-44)非同义体细胞突变。
- 20.5%的标本有RAS亚家族突变。
临床怎么用
- 突变负荷可作为FTC预后预测指标,独立于组织学分类。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Follicular thyroid carcinoma (FTC) is classified into minimally invasive (miFTC), encapsulated angioinvasive (eaFTC), and widely invasive (wiFTC) subtypes, according to the 2017 World Health Organization guidelines. The genetic signatures of these subtypes may be crucial for diagnosis, prognosis, and treatment but have not been described. OBJECTIVE: Identify and describe the genetic underpinnings of subtypes of FTC. METHODS: Thirty-nine tumors, comprising 12 miFTCs, 17 eaFTCs, and 10 wiFTCs, were whole-exome sequenced and analyzed. Somatic mutations, constitutional sequence variants, somatic copy number alterations, and mutational signatures were described. Clinicopathologic parameters and mutational profiles were assessed for associations with patient outcomes. RESULTS: Total mutation burden was consistent across FTC subtypes, with a median of 10 (range 1 to 44) nonsynonymous somatic mutations per tumor. Overall, 20.5% of specimens had a mutation in the RAS subfamily (HRAS, KRAS, or NRAS), with no notable difference between subtypes. Mutations in TSHR, DICER1, EIF1AX, KDM5C, NF1, PTEN, and TP53 were also noted to be recurrent across the cohort. Clonality analysis demonstrated more subclones in wiFTC. Survival analysis demonstrated worse disease-specific survival in the eaFTC and wiFTC cohorts, with no recurrences or deaths for patients with miFTC. Mutation burden was associated with worse prognosis, independent of histopathological classification. CONCLUSIONS: Though the number and variety of somatic variants are similar in the different histopathological subtypes of FTC in our study, mutational burden was an independent predictor of mortality and recurrence.
引用
- Nicolson NG, Murtha TD, Dong W, et al. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology. J Clin Endocrinol Metab. 2018. PMID: 29726952. doi:10.1210/jc.2018-00277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。